Dr. Mohammed Serve as Head of signal detection section at Saudi food and drug authority. In this role, he has several initiatives to enhance the drug safety regulation in the kingdom of Saudi Arabia. In 2008 Dr. Fouda received his bachelor’s degree in pharmaceutical sciences from king Saud university he also awarded his doctor of pharmacy degree in 2014 from Massachusetts College of Pharmacy and Health Sciences University. Dr. Fouda is currently a member of several international reference groups.

Shahinaz, a pharmacist with over 20 years in pharmacy and the pharmaceutical industry, is a Pharmacovigilance Consultant and Lead Auditor across the EMEA region. She began as a clinical pharmacist at Cairo University Medical School and advanced to an internal auditor role. Transitioning to the pharmaceutical industry, she worked in Regulatory Affairs before specializing in Pharmacovigilance as a regional QPPV and later as a PVQA Lead Auditor. Shahinaz is active in the ISOP Special Interest Group, contributing to global pharmacovigilance certifications, and frequently speaks at international conferences on patient and drug safety

Dr. Maha Mohammed holds a BSc. Pharm. 2009, Master in Pharmacology, and toxicology Azhar University. 2018. She is the General Manager of Pharmaceutical Vigilance– Egyptian Drug Authority (EDA). Previously, she was a team leader of Cairo regional pharmacovigilance centre & Senior PV specialist. Maha Mohammed is has fourteen years of experience working in regulatory authority. Dr Maha specializes in pharmacovigilance and is responsible of Supervising the Egyptian Pharmceutical Vigilance Center, including ICSRs management unit, Signal detection unit, emerging safety issues unit, follow up unit and PRBER Unit, PV system, PV inspections ..etc.

Muhanad H. Alharbi is currently working as head of data capture section at the National Pharmacovigilance Center, in the Saudi Food and Drug Authority (SFDA) since 2019. He awarded his master degree in pharmacology from Aston University UK. He is the project manager of pharmacovigilance regional offices. He also has trained in several courses in drug safety and pharmacovigilance and he has participated in a number of pharmacovigilance activities.

A doctor graduated from the University of Algiers, holding a Diploma of Advanced Studies from the Faculty of Medicine of Paris (France), a university degree in pharmacovigilance from the university Claude Bernard of Lyon and a doctoral thesis in clinical pharmacology at the Faculty of Medicine of Besançon. She took part in the creation of the CNPM with its founder Professor A Helali in 1998. Since 2016, she has introduced the concept of Phytovigilance, Réactovigilance, Cosmetovigilance, in addition to the vigilance of the drug, the medical device and the vaccine already established. Teacher at the Faculty of Medicine of Algiers. Editor of the independent Medical journal "la Revue Prescrire" since 2007.

Doaa Soliman holds a B.Sc. in Pharmaceutical Science, an Egyptian Board of Healthcare Management certification, and a Master’s in Healthcare Quality Management. With 10 years of experience in the healthcare sector, she has worked as an inpatient and community pharmacist, as well as in supply chain management, specializing in pharmacovigilance (PV). As an Administrative Manager, she oversees three units: PV Training, PV Inspection, and Pharmacovigilance System Master File (PSMF) Assessment. She has contributed to the Egyptian Drug Authority's (EDA) global benchmarking program with the World Health Organization (WHO) and led PV inspections across Egypt, ensuring compliance with safety standards.

Rania Shousha specializes in clinical studies regulation at the Egyptian Regulatory Authority, with over 7 years of experience. She oversees clinical trial protocols, participant safety, and data integrity, ensuring compliance with regulatory standards. She also advises pharmaceutical companies on study design, data collection, and analysis. Rania earned a Master's in Clinical Pharmacy with honors from the University of Tanta and completed a clinical pharmacy residency at a government hospital. She is currently pursuing a PhD in Pharmacology and Toxicology at Cairo University.Rania represents the Egyptian Drug Authority (EDA) at the International Council for Harmonization (ICH) as a member of the ICH M15 Expert Working Group.